rs78587006
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_015340.4(LARS2):c.2547T>C(p.Ala849Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00298 in 1,609,898 control chromosomes in the GnomAD database, including 216 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_015340.4 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LARS2 | NM_015340.4 | c.2547T>C | p.Ala849Ala | synonymous_variant | Exon 22 of 22 | ENST00000645846.2 | NP_056155.1 | |
LARS2 | NM_001368263.1 | c.2547T>C | p.Ala849Ala | synonymous_variant | Exon 21 of 21 | NP_001355192.1 | ||
LARS2 | XM_017006042.2 | c.*4T>C | 3_prime_UTR_variant | Exon 21 of 21 | XP_016861531.1 | |||
LARS2 | XM_047447830.1 | c.*4T>C | 3_prime_UTR_variant | Exon 20 of 20 | XP_047303786.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00314 AC: 478AN: 152190Hom.: 12 Cov.: 32
GnomAD3 exomes AF: 0.00616 AC: 1519AN: 246402Hom.: 52 AF XY: 0.00558 AC XY: 744AN XY: 133430
GnomAD4 exome AF: 0.00297 AC: 4328AN: 1457590Hom.: 204 Cov.: 31 AF XY: 0.00293 AC XY: 2123AN XY: 725278
GnomAD4 genome AF: 0.00313 AC: 477AN: 152308Hom.: 12 Cov.: 32 AF XY: 0.00340 AC XY: 253AN XY: 74484
ClinVar
Submissions by phenotype
not provided Benign:3
- -
- -
- -
not specified Benign:2
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Ala849Ala in exon 22 of LARS2: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 10.1% (18/178) of J apanese chromosomes from a broad population by the 1000 Genomes Project (http:// www.ncbi.nlm.nih.gov/projects/SNP; dbSNP rs78587006). -
LARS2-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at